Telix Pharmaceuticals annual gross margin
2022
2023
2024
2025
Telix Pharmaceuticals's gross margin was 53.05% for fiscal 2025.
View full Telix Pharmaceuticals company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 53.05% | −12.03 pp |
| 2024 | 2024-12-31 | 65.08% | +2.15 pp |
| 2023 | 2023-12-31 | 62.93% | +3.63 pp |
| 2022 | 2022-12-31 | 59.29% | — |
Between the periods ended 2022-12-31 and 2025-12-31, Telix Pharmaceuticals's gross margin decreased from 59.29% to 53.05%, a change of −6.24 percentage points.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Telix Pharmaceuticals source filings ↗